Guardion Health Sciences, Inc. Common Stock
GHSI
GHSI was delisted on the 11th of October, 2024.
11 hedge funds and large institutions have $348K invested in Guardion Health Sciences, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.22% less ownership
Funds ownership: 5.31% → 5.09% (-0.22%)
21% less funds holding
Funds holding: 14 → 11 (-3)
30% less capital invested
Capital invested by funds: $498K → $348K (-$150K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.04K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$10.3K |
| 2 |
Barclays
London,
United Kingdom
|
-$5.48K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$133 |
GHSI Hedge Fund Activity: Q4 2023 in Review
11 of the 6,871 institutional investors tracked by Wall St. Rank reported a position in Guardion Health Sciences, Inc. Common Stock (GHSI) for Q4 2023, worth a combined $348K — down 30% from $498K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of GHSI and 0 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Tower Research Capital (TRC), adding an estimated $1.04K. The largest seller was Renaissance Technologies, cutting an estimated $10.3K.
- 11 institutional investors held Guardion Health Sciences, Inc. Common Stock (GHSI) as of Q4 2023, down from 14 in Q3 2023.
- Funds reported $348K of Guardion Health Sciences, Inc. Common Stock stock for Q4 2023, down 30% quarter-over-quarter.
- 0 funds opened new Guardion Health Sciences, Inc. Common Stock positions in Q4 2023 and 3 closed out, a net change of -3 holders.
- The largest Guardion Health Sciences, Inc. Common Stock buyer in Q4 2023 was Tower Research Capital (TRC), an estimated $1.04K added.
- The largest Guardion Health Sciences, Inc. Common Stock seller in Q4 2023 was Renaissance Technologies, an estimated $10.3K sold.
Based on aggregated 13F filings for Q4 2023.